WASHINGTON — A form of immunotherapy that could get rid of a person's allergy to peanuts is likely within five years, even as the condition appears to grow more and more common, a U.S. expert said on Thursday.
Peanut allergy often appears in the first three years of life, with the allergic reaction to eating peanuts ranging from a minor irritation all the way to a life-threatening, whole-body allergic response called anaphylaxis.
Many children grow out of other food allergies such as milk or eggs, but only about 20 percent lose their peanut allergy.
Dr. Wesley Burks, a food allergy expert at Duke University Medical Center in Durham, North Carolina, wrote in the Lancet medical journal that a solution appears to be on the horizon.
"I think there's some type of immunotherapy that will be available in five years. And the reason I say that is that there are multiple types of studies that are ongoing now," Burks said in a telephone interview.
Read the full Reuters story here.
Latest from Quality Assurance & Food Safety
- USDA Indefinitely Delays Salmonella Testing Program for Raw Breaded Stuffed Chicken
- American Soybean Association Names New Industry Relations Leadership
- Babybel Transitions From Cellophane to Paper Packaging
- Ambriola Company Recalls Cheese Products Due to Listeria Risk
- Horizon Family Brands Acquires Maple Hill Creamery
- Kellanova Shares Top Five Consumer Packaged Goods Tech Trends Shaping 2026
- Stay Ahead of Supply Chain Pressure
- Brendan Niemira Named IFT Chief Science and Technology Officer